Abraham Ceesay sold $64K of RAPP stock

Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP), sold 2,210 shares of RAPP stock worth $64K, per an SEC Form 4 filed Oct 23, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 21, 2026, 2 days before it was made public.

RAPP has moved +3.6% since the trade date, from $25.06 to $25.96 (Nov 10, 2026 close).